Piramal acquires Caladryl from Valeant Pharma

November 02, 2013 02:39 am | Updated 02:39 am IST - MUMBAI

Piramal Enterprises Ltd. (formerly Piramal Healthcare Ltd.) has acquired over-the-counter (OTC) brand Caladryl in India from Valeant Pharmaceuticals International, Inc. for an unspecified amount.

Caladryl is an anti-pruritic solution known for dermatosis application for minor skin irritations and itching.

Valeant Pharmaceuticals had acquired the rights to the Caladryl brand from Johnson & Johnson in 2012.

This acquisition enables Piramal Enterprises to widen its consumer products portfolio in the skin care segment, the company.

The company covers more than 1,00,000 towns in the country.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.